HomeNDC LookupRxCUI directory › RxCUI 1665519

30 ML levofloxacin 25 MG/ML Injection — RxCUI 1665519

RxNorm drug concept · Semantic clinical drug
RxCUI 1665519 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665519
Official name30 ML levofloxacin 25 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevofloxacin 750 MG per 30 ML Injection; levoFLOXacin 750 MG in 30 ML Injection
FDA products mapped4
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Levofloxacin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Levofloxacin injection is used when getting the medicine directly into your vein is a better option for you — for example, if you're in the hospital with a serious infection, if yo...
  • Why am I getting this antibiotic through an IV instead of a pill?
  • The more common side effects are nausea, headache, diarrhea, dizziness, insomnia, and constipation — uncomfortable, but manageable. The ones to take seriously are tendon pain or a...
  • What side effects should I watch for and which ones are really serious?
📖 Read our full Levofloxacin Injection guide →

🕸️ Concept Web — How 30 ML levofloxacin 25 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 30 ML levofloxacin 25 MG/ML Injection RxCUI 1665519

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Levofloxacin 82122
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Levofloxacin Injection 1665494
    • Levofloxacin Injectable Product 1163464
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Levofloxacin 25 MG/ML 316144

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Levofloxacin 25 MG/ML SCDC · 316144
  • Levofloxacin Injection SCDF · 1665494
  • Levofloxacin Injectable Product SCDG · 1163464

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 1665519 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
55150-0156-20 1 VIAL, SINGLE-USE in 1 CARTON (55150-156-20) / 20 mL in 1... Levofloxacin Eugia US LLC 2013-01-24
55150-0157-30 1 VIAL, SINGLE-USE in 1 CARTON (55150-157-30) / 30 mL in 1... Levofloxacin Eugia US LLC 2013-01-24
68083-0394-01 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-394-01) / 20 mL in 1... LEVOFLOXACIN Gland Pharma Limited 2020-04-22
68083-0395-01 1 VIAL, SINGLE-DOSE in 1 CARTON (68083-395-01) / 30 mL in 1... LEVOFLOXACIN Gland Pharma Limited 2020-04-22
Observed labelers: Eugia US LLC (2) · Gland Pharma Limited (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.